Wilson Kevin S. 4
4 · HESKA CORP · Filed Jun 14, 2023
Insider Transaction Report
Form 4
HESKA CORPHSKA
Wilson Kevin S.
President and COO
Transactions
- Disposition to Issuer
Common Stock
2023-06-13$120.00/sh−162,763$19,531,560→ 0 total(indirect: By LLC) - Disposition to Issuer
Common Stock
2023-06-13$120.00/sh−383,447$46,013,640→ 0 total - Disposition to Issuer
Non-Qualified Stock Option (right to buy)
2023-06-13−20,851→ 0 totalExercise: $69.77From: 2018-03-07Exp: 2028-03-06→ Common Stock (20,851 underlying) - Award
Common Stock
2023-06-13+211,375→ 383,447 total - Disposition to Issuer
Common Stock
2023-06-13$120.00/sh−9,000$1,080,000→ 0 total(indirect: By Spouse) - Disposition to Issuer
Common Stock
2023-06-13$120.00/sh−138,743$16,649,160→ 0 total(indirect: by Wilson Family Tr.)
Footnotes (3)
- [F1]Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated as of March 31, 2023, by and among the Issuer, Antech Diagnostics, Inc., a California corporation ("Acquiror"), Helsinki Merger Sub LLC, a Delaware limited liability company and a wholly-owned subsidiary of Acquiror, and, solely for purposes of Section 9.15 of the Merger Agreement, Mars, Incorporated, a Delaware corporation, these shares of performance-based restricted stock of the Issuer were fully accelerated assuming maximum level of performance immediately prior to the effectiveness of the merger.
- [F2]Disposed of pursuant to the Merger Agreement in exchange for cash consideration of $120.00 per share of common stock of the Issuer (the "Merger Consideration") on the effective date of the merger.
- [F3]Stock options of the Issuer were canceled in the merger in exchange for an amount in cash equal to the difference, if any, between the Merger Consideration and the exercise price of such stock options.